Skip to main content

What the FDA labels say about taking them together

Clarithromycin and darifenacin

Darifenacin's FDA label of February 10, 2026 names clarithromycin in its drug interactions section; the clarithromycin label PlainMeds reads does not name darifenacin. The darifenacin label: “The daily dose of darifenacin extended-release tablets should not exceed 7.5 mg when co-administered with potent CYP3A4 inhibitors.”

Check it at the source: the clarithromycin FDA label on DailyMed (effective April 9, 2026, Solaris Pharma Corporation); the darifenacin FDA label on DailyMed (effective February 10, 2026, Torrent Pharmaceuticals Limited).

What does the clarithromycin label say about darifenacin?

Clarithromycin's label (effective April 9, 2026) does not name darifenacin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Clarithromycin), Solaris Pharma Corporation, effective April 9, 2026 (SPL set 4d42821d-ce7a-7d64-e063-6294a90a0875), via openFDA; the full label on DailyMed

What does the darifenacin label say about clarithromycin?

Darifenacin label, drug interactions

The daily dose of darifenacin extended-release tablets should not exceed 7.5 mg when co-administered with potent CYP3A4 inhibitors (for example, ketoconazole, itraconazole, ritonavir, nelfinavir, clarithromycin and nefazadone).

Source: FDA drug label (Darifenacin), Torrent Pharmaceuticals Limited, effective February 10, 2026 (SPL set e84f1ae3-b9a2-4a15-a299-c75373891cc1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Clarithromycin generic labelers
8Darifenacin generic labelers
ClarithromycinDarifenacin
Labeled forBacterial infections, Acid reflux and ulcersOveractive bladder
Boxed warningNoNo
Pharmacy cost (NADAC)$0.466 per tablet 500 mg tablet$0.432 per tablet 15 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?